Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Solid tumor DNA content analysis.

Adel K El-Naggar1, Philippe Vielh

  • 1Department of Pathology, The University of Arizona, Tucson, AZ, USA.

Methods in Molecular Biology (Clifton, N.J.)
|February 21, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Editor's Note: Akt/mTOR Counteract the Antitumor Activities of Cixutumumab, an Anti-Insulin-like Growth Factor I Receptor Monoclonal Antibody.

Molecular cancer therapeutics·2026
Same author

NOTCH1 acts as a tumor suppressor that induces early differentiation in head and neck cancer.

JCI insight·2026
Same author

Axitinib plus Avelumab in Recurrent/Metastatic Adenoid Cystic Carcinoma: Biomarker Analysis and Updated Results of the Phase II Trial.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Same author

Sustained Response to Lorlatinib and Pemetrexed in <i>ALK</i> Fusion-Positive Anaplastic Thyroid Carcinoma With Multiple Distant Metastases: A Case Report.

JCO precision oncology·2026
Same author

Recurrent Maxillary Ameloblastoma Presenting as an External Auditory Canal Mass.

The Laryngoscope·2026
Same author

Elucidating cooperative genetic events in DCIS progression in mutant <i>p53</i>-driven breast cancer.

Proceedings of the National Academy of Sciences of the United States of America·2026

Flow cytometric DNA content analysis offers a fast and dependable method for assessing tumor DNA ploidy and proliferation. This technique is valuable for evaluating breast, colon, lung, and bladder carcinomas alongside other prognostic factors.

Area of Science:

  • Oncology
  • Molecular Biology
  • Pathology

Background:

  • Accurate prognostic assessment is crucial for effective cancer treatment strategies.
  • Traditional prognostic factors may benefit from complementary biological data.
  • Tumor ploidy and proliferative fraction are key biological characteristics.

Purpose of the Study:

  • To evaluate the utility of flow cytometric DNA content analysis for tumor assessment.
  • To determine the suitability of archival and fresh specimens for this analysis.
  • To explore the application of this technique in early-stage carcinomas.

Main Methods:

  • Flow cytometry was employed for DNA content analysis.
  • Analysis focused on determining DNA ploidy and proliferative fraction.

Related Experiment Videos

  • Both fresh and archival tumor specimens were utilized.

    • Main Results:

    • Flow cytometry provides rapid and reliable DNA ploidy analysis.
    • The proliferative fraction of tumor cells can be accurately determined.
    • The technique is applicable to both fresh and archival specimens.
    • Data obtained is useful for biological assessment of carcinomas.

    Conclusions:

    • Flow cytometric DNA content analysis is a valuable tool in cancer diagnostics.
    • This method aids in the biological assessment of early-stage breast, colon, lung, and bladder carcinomas.
    • It complements traditional prognostic factors for improved patient management.